Zobrazeno 1 - 10
of 879
pro vyhledávání: '"James P. Chung"'
Autor:
Jing-Xing Li, Yu-Hsun Wang, Henry Bair, Shu-Bai Hsu, Connie Chen, James Cheng-Chung Wei, Chun-Ju Lin
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-3 (2024)
Abstract We appreciate your interest in our study. This study contrasts with Dorney et al.‘s focus on the first 21 days. We conducted a re-analysis regarding selection bias and found consistent results. Our research highlights the elevated risk of
Externí odkaz:
https://doaj.org/article/0c20c7a982714957958a46b3ff3ef943
Autor:
Chih-Wei Chen, Hsun-Hua Lee, Shu-Hao Chang, Yi-Ling Chen, Yu-Hsun Wang, Pui-Ying Leong, James Cheng-Chung Wei
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 11, Pp 102559- (2024)
Background: Many patients who recovered from COVID-19 still suffer from chronic fatigue syndrome (CFS). It was observed that patients with comorbidities were more prone to developing CFS. This research investigates the risk of post-COVID-19 CFS to as
Externí odkaz:
https://doaj.org/article/ebed3bb0787545f89f5d2abbe3fa3aea
Publikováno v:
EClinicalMedicine, Vol 75, Iss , Pp 102794- (2024)
Summary: Background: Autoimmune diseases are known to be associated with an increased risk of cancer. Whether maternal immune dysregulation can have an impact on the development of haematological malignancies in offspring remains uncertain. Therefore
Externí odkaz:
https://doaj.org/article/d5879203cf514277b7102c8c68288381
Autor:
Weijie Wang, Yu-Hsun Wang, Ching-Hua Huang, Tsung-Hsueh Hsieh, Gema Hernández Ibarburu, James Cheng-Chung Wei
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Paxlovid has been shown to be effective in reducing mortality and hospitalization rates in patients with coronavirus disease 2019 (COVID-19). It is not known whether Paxlovid can reduce the risk of cardiovascular diseases (CVD) in
Externí odkaz:
https://doaj.org/article/a0cc0ed726ba4bcfa9e5bc7b61e73124
Autor:
Huang-Hsi Chen, Kevin Sheng-Kai Ma, Chen Dong, Wen-Jung Chang, Kuan-Rong Gao, Wuu-Tsun Perng, Jing-Yang Huang, James Cheng-Chung Wei
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/db802d4cf6254ef5845ca9d0a26c1f80
Autor:
Sofia Ramiro, James Cheng-Chung Wei, Michael J Nissen, Louis Bessette, Soyi Liu-Leage, Cédric Lukas, Rebecca Bolce, Pendleton Wickersham, Tommaso Panni, Boris Janos
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Background The Assessment of SpondyloArthritis international Society-European Alliance of Associations for Rheumatology recommendations for axial spondyloarthritis (axSpA) management include patient assessment for biological disease-modifying antirhe
Externí odkaz:
https://doaj.org/article/7e97d98611d746dc8e039354f01b085a
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionTo verify our hypothesis that psoriatic arthritis (PsA) is mainly genetically predetermined and distinct from psoriasis (PsO), we use the TriNetX database to investigate whether intrinsic factors outweigh externals in PsA emergence in PsO
Externí odkaz:
https://doaj.org/article/64b190e165a842d48a5c03c99234422a
Autor:
Natalia Mikhailichenko, Te-Jen Lai, James Cheng-Chung Wei, Tsukasa Takahashi, Jun Takanari, Kazunori Goto
Publikováno v:
Journal of Pharmacy & Pharmacognosy Research, Vol 12, Iss 1, Pp 154-165 (2024)
Context: Recently, new intervention tools at the mild cognitive impairment (MCI) stage are needed to prevent dementia, including Alzheimer’s disease (AD). Aims: To evaluate whether a standardized Asparagus officinalis stem (ETAS) extract, as a f
Externí odkaz:
https://doaj.org/article/1347ff78950c433bbd2d64ffdc45079e
Autor:
Fu-Shun Yen, Ming-Chih Hou, James Cheng-Chung Wei, Ying-Hsiu Shih, Chii-Min Hwu, Chih-Cheng Hsu
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background Patients with type 2 diabetes (T2D) tend to have nonalcoholic fatty liver disease (NAFLD) with poorer prognosis. We performed this research to compare the risks of cardiovascular diseases, cirrhosis, liver-related mortality, and c
Externí odkaz:
https://doaj.org/article/c94e0cd597eb4624970fb57d981a755a
Autor:
Xiao-Na Ma, Mei-Feng Shi, Shiow-Ing Wang, Wei Feng, Shu-Lin Chen, Xiao-Qin Zhong, Qing-Ping Liu, James Cheng-Chung Wei, Chang-Song Lin, Qiang Xu
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
ObjectiveTo compare the effects of tofacitinib and adalimumab on the risk of adverse lipidaemia outcomes in patients with newly diagnosed rheumatoid arthritis (RA).MethodsData of adult patients newly diagnosed with RA who were treated with tofacitini
Externí odkaz:
https://doaj.org/article/dcf5cb99fc20481d9f83814ebf44d544